InvestorsHub Logo
Followers 51
Posts 4564
Boards Moderated 0
Alias Born 12/14/2009

Re: None

Wednesday, 10/22/2014 2:15:21 AM

Wednesday, October 22, 2014 2:15:21 AM

Post# of 15662
SQUIRE PATTON INKS EBOLA DRUGMAKER: Hemispherx BioPharma, Inc. has hired Squire Patton Boggs to help raise awareness and tackle regulatory issues around two potential Ebola drugs. The company believes that two of its products — the drugs Ampligen and Alferon — could possibly be effective as treatments for the virus that’s currently ravaging several West African countries. Squire Patton will work communicating the company’s message to officials in the United States and abroad. “We are pleased to establish a strategic relationship with [Squire Patton Boggs], one of the world’s finest governmental, international relations, biopharma licensing and corporate M&A law firms,” said Thomas Equels of Hemispherx in a statement. “We welcome [Squire Patton] to the Hemispherx team effort to bring our experimental drug Ampligen and FDA approved drug Alferon online as potential therapeutics for Ebola and other lethal viruses for which no effective therapy exists.” Stuart Pape, Ed Newberry, Taryn Frideres, Robert Kapla and Kevin O'Neill will all work on the account for Squire Patton.

http://www.politico.com/politicoinfluence/1014/politicoinfluence15751.html

Google their names. Very, very, very impressive.